← FDA Drug Approvals (Drugs@FDA)

ICATIBANT ACETATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA · Approved 2020-07-13

Drug application

FDA Application #

ANDA212446

Application type

Abbreviated New Drug Application (Generic)

Brand name

ICATIBANT ACETATE

Generic name

ICATIBANT

Active ingredients

ICATIBANT ACETATE

Dosage form

INJECTABLE

Route

SUBCUTANEOUS

Marketing status

Prescription

Sponsor

CIPLA

Manufacturer

Cycle Pharmaceuticals Ltd-Uk

First approval

2020-07-13

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown